We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FUSN market cap is 1.48B. The company's latest EPS is USD -1.3755 and P/E is -15.57.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 166k | 140k | 28k | 34k | 2.01M |
| Operating Income | -23.81M | -24.42M | -24.86M | -26.71M | -19.39M |
| Net Income | -24.01M | -24.62M | -24.29M | -25.18M | -17.25M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.44M | 1.46M | 2.07M |
| Operating Income | -77.06M | -82.02M | -88.03M | -99.23M |
| Net Income | -78.33M | -81.05M | -87.61M | -94.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 238.49M | 219.06M | 266.55M | 268.29M | 253.38M |
| Total Liabilities | 55.35M | 56.84M | 65.72M | 65.33M | 64.91M |
| Total Equity | 183.14M | 162.22M | 200.83M | 202.96M | 188.47M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 310.68M | 252.27M | 219.06M | 285.84M |
| Total Liabilities | 16.16M | 20.82M | 56.84M | 63.36M |
| Total Equity | 294.51M | 231.46M | 162.22M | 222.48M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -53.91M | -73.28M | -25.44M | -45.02M | -63.86M |
| Investing | 66.02M | 23.09M | -24.53M | -50.85M | -37.52M |
| Financing | 40.6M | 40.73M | 59.52M | 83.82M | 84.15M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.77M | -75.74M | -73.28M | -81.8M |
| Investing | -210.45M | 37.77M | 23.09M | -42.76M |
| Financing | 265.51M | 347k | 40.73M | 142.01M |
| Market Cap | 1.48B |
| Price to Earnings Ratio | -15.57 |
| Price to Sales Ratio | 714 |
| Price to Cash Ratio | 24.05 |
| Price to Book Ratio | 6.64 |
| Dividend Yield | - |
| Shares Outstanding | 68.99M |
| Average Volume (1 week) | 467.42k |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | 428.89% |
| 52 Week High | 21.58 |
| 52 Week Low | 2.31 |
| Spread (Intraday) | 1.69 (7.32%) |
| Company Name | Fusion Pharmaceuticals Inc |
| Address |
270 longwood road south hamilton, ontario L8P 0A6 |
| Website | https://www.fusionpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
